Related Experiment Video
Updated: Jun 2, 2026

COVID-19 Seroprevalence Test for IgG Antibody Levels Among Healthy Donors Across Different Pandemic Phases in Jeddah
Published on: June 24, 2025
Hepatitis A seroprevalence among infants aged 12 months in Ankara
Osman Tolga Ince1, S Songül Yalçin, Kadriye Yurdakök
1Division of Social Pediatrics, Department of Pediatrics, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Insights
Hepatitis A seroprevalence in Ankara infants was 23.5%. Understanding maternal antibody decay is crucial for optimal infant hepatitis A vaccination timing in Turkey.
Area of Science:
- Pediatrics
- Infectious Diseases
- Immunology
Background:
- Hepatitis A seroprevalence studies inform infection understanding and vaccination response.
- Maternal antibodies can impact infant immune responses to hepatitis A vaccination.
- Optimal infant vaccination timing requires knowledge of maternal antibody decay.
Purpose of the Study:
- To determine hepatitis A seroprevalence in 12-month-old infants in Ankara.
- To assess gender-based differences in hepatitis A seropositivity among infants.
- To inform hepatitis A vaccination strategies in Turkey.
Main Methods:
- A cross-sectional study was conducted.
- 601 healthy infants aged 12 months in Ankara were enrolled.
- Hepatitis A seropositivity was assessed.
Main Results:
- Overall hepatitis A seropositivity was 23.5% among the infants.
- No significant gender difference in seropositivity was observed (22.6% males, 24.5% females).
Conclusions:
- Hepatitis A infection is prevalent in young children in Ankara.
- Further seroprevalence studies across different age groups are needed.
- Optimal hepatitis A vaccination strategies require more data on maternal antibody decay and infant seroprevalence.
Abstract:
Seroprevalence studies in various age groups contribute to a better understanding of hepatitis A infection and response to hepatitis A immunization. Hepatitis A seroprevalence in 12-month-old infants from Ankara was studied. Among 601 healthy infants, overall hepatitis A seropositivity was found to be 23.5%. There were no gender differences in seropositivity (22.6% for male and 24.5% for female infants). Although vaccination of infants would be an ideal prevention strategy, presence of maternal anti-hepatitis A virus (HAV) antibody interferes with the immune response to hepatitis A vaccine in infants and young children. Therefore, further knowledge about decay of maternal antibody in infants is important in determining the optimal age for vaccination against hepatitis A. There is no recommendation for routine hepatitis A vaccination in Turkey. However, we need more seroprevalence studies in different age groups to decide the appropriate timing/age of vaccination.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Poliomyelitis
Toxoplasmosis
